Login | Register

First Gene Therapy Recommended For European Approval

A gene therapy medicine has been recommended for authorization in the European Union for the first time. Glybera (alipogene tiparvovec), developed by uniQure, a Dutch biotech, is designed for patients with the genetic disorder lipoprotein lipase deficiency (LPLD) who have severe or multiple pancreatitis attacks, despite dietary fat restriction...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *